An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)

NCT01483898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

BIOLOGICAL: Ixmyelocel-T
OTHER: Placebo

Sponsor

Vericel Corporation